Human Recombinant FGF19 protein (V2LY-0526-LY4057)

Go to compare Compare Online Inquiry
Request for COA
Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Expressed Host
E. coli
Protein Species
Human
Protein Construction
This product is Human Recombinant FGF19 protein consist of Amino Acid: 27-216 and predicts a molecular mass of 21.4 kDa.
Molecule Mass
21.4 kDa
Verified
HPLC
Sequence
Amino Acid: 27-216
Species
Human

Formulations & Storage [For reference only, actual COA shall prevail!]

Purity
≥95% as determined by SDS-PAGE. ≥95% as determined by SEC-HPLC.
Endotoxin
Please contact us for more information.
Format
Lyophilized
Reconstitution
Allow the vial and reconstitution buffer to equilibrate to room temperature. Briefly centrifuge or tap down the vial to ensure that all lyophilized powder is collected at the bottom of the vial. For the reconstitution of this product, we recommend adding PBS or sterile water to achieve a final antibody concentration of 1 mg/mL. Allow the vial to reconstitute for 10-15 minutes at room temperature with gentle agitation. Avoid vigorous shaking that can cause foaming and antibody denaturation. Aliquot into volumes based on your experiment and store liquid protein at -20°C or -80°C for long time.
Buffer
Lyophilized from sterile PBS
Preservative
None
Storage
Samples are stable for up to twelve months from date of receipt at -20°C to -80°C. Store it under sterile conditions at -20°C to -80°C. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
More Infomation

Target

Full Name
Fibroblast Growth Factor 19
Research Area
Involved in the suppression of bile acid biosynthesis through down-regulation of CYP7A1 expression, following positive regulation of the JNK and ERK1/2 cascades. Stimulates glucose uptake in adipocytes. Activity requires the presence of KLB and FGFR4.
Biological Process
Animal organ morphogenesis Source: GO_Central
Cell differentiation Source: GO_Central
Fibroblast growth factor receptor signaling pathway Source: MGI
Negative regulation of bile acid biosynthetic process Source: UniProtKB
Negative regulation of gene expression Source: UniProtKB
Nervous system development Source: ProtInc
Positive regulation of cell population proliferation Source: MGI
Positive regulation of ERK1 and ERK2 cascade Source: UniProtKB
Positive regulation of gene expression Source: GO_Central
Positive regulation of glucose import Source: UniProtKB
Positive regulation of JNK cascade Source: UniProtKB
Positive regulation of protein phosphorylation Source: UniProtKB
Regulation of cell migration Source: GO_Central
Cellular Location
Secreted

Chrysavgis, L., Giannakodimos, I., Chatzigeorgiou, A., Tziomalos, K., Papatheodoridis, G., & Cholongitas, E. (2022). The role of fibroblast growth factor 19 in the pathogenesis of nonalcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology, 16(9), 835-849.

Ursic-Bedoya, J., Chavey, C., Desandré, G., Meunier, L., Dupuy, A. M., Reyes, I. G. D., ... & Gregoire, D. (2022). Fibroblast growth factor 19 stimulates water intake. Molecular Metabolism, 60, 101483.

Liu, T., Tang, X., Cui, Y., Xiong, X., Xu, Y., Hu, S., ... & Wang, C. (2022). Fibroblast growth factor 19 improves LPS-induced lipid disorder and organ injury by regulating metabolomic characteristics in mice. Oxidative Medicine and Cellular Longevity, 2022.

Mohamed, G. A., Nashaat, E. H., Fawzy, H. M., & ElGhandour, A. M. (2022). Assessment of fibroblast growth factor 19 as a non-invasive serum marker for hepatocellular carcinoma. World Journal of Hepatology, 14(3), 623.

Chen, H., Li, J., Zhang, D., Zhou, X., & Xie, J. (2021). Role of the fibroblast growth factor 19 in the skeletal system. Life Sciences, 265, 118804.

Chen, Z., Jiang, L., Liang, L., Koral, K., Zhang, Q., Zhao, L., ... & Tao, J. (2021). The role of fibroblast growth factor 19 in hepatocellular carcinoma. The American Journal of Pathology, 191(7), 1180-1192.

Zhou, Y., Yang, L., Bo, C., Zhang, X., Zhang, J., & Li, Y. (2021). MicroRNA-9-3p Aggravates Cerebral Ischemia/Reperfusion Injury by Targeting Fibroblast Growth Factor 19 (FGF19) to Inactivate GSK-3β/Nrf2/ARE Signaling. Neuropsychiatric Disease and Treatment, 17, 1989.

Guo, A., Li, K., & Xiao, Q. (2020). Fibroblast growth factor 19 alleviates palmitic acid-induced mitochondrial dysfunction and oxidative stress via the AMPK/PGC-1α pathway in skeletal muscle. Biochemical and Biophysical Research Communications, 526(4), 1069-1076.

Maeda, T., Kanzaki, H., Chiba, T., Ao, J., Kanayama, K., Maruta, S., ... & Kato, N. (2019). Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma. BMC cancer, 19(1), 1-9.

Ask a question We look forward to hearing from you.
0 reviews or Q&As
Loading...
Have you used Human Recombinant FGF19 protein?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

online inquiry
Online Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.